Abstract |
Approximately 20% of a dose of estragole, a naturally occurring flavoring agent, was excreted in the urine of outbred male CD -1 mice as a conjuage (presumably the glucuronide) of 1'-hydroxyestragole, Estragole and its 1'-hydroxy metabolite caused significant increases in the incidences of hepatocellular carcinomas in male CD-1 mice that received the compounds by sc injection at 1-22 days of age. Estragole induced hepatocellular carcinomas by 15 months in 23 and 39% of the mice that received total doses of 4.4 and 5.2 mumoles, respectively, and lived to an age of 12 months or more. Of the 12-month survivors given a total dose of 4.4 mumoles of 1'-hydroxyestragole, 70% developed hepatocellular carcinomas; the incidence in mice that received only the vehicle ( trioctanoin) was 12%. Multiple tumors ocurred in 5, 28, 64, and 0%, respectively, of the mice in each of these 4 groups. Of the mice given a total dose of 4.4 mumoles of 1'-hydroxysafrole, 59developed hepatocellular carcinomas; 39% of the mice bore multiple liver tumors. As previsously demonstrated for 1'-acetoxysafrole, 1'-acetoxyestragole and 1'-acetoxy-1-allyl-4-methoxynaphthalene reacted nonenzymatically with guanosine and inosine to form adducts. These electrophilic esters were strongly mutagenic for the Salmonella typhimurium missense mutant TA100. 1'-Acetoxyallybenzene had little or no activity in either of these tests. Attempts to demonstrate liver-mediated mutagenicty for 1'-hydroxysafrole and 1'-hydroxyestragole in the bacterial test system were unsuccessful.
|
Authors | N R Drinkwater, E C Miller, J A Miller, H C Pitot |
Journal | Journal of the National Cancer Institute
(J Natl Cancer Inst)
Vol. 57
Issue 6
Pg. 1323-31
(Dec 1976)
ISSN: 0027-8874 [Print] United States |
PMID | 187802
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Allylbenzene Derivatives
- Anisoles
- Carcinogens
- Flavoring Agents
- Glucuronates
- Mutagens
- Nucleosides
- 1'-hydroxyestragole
- estragole
|
Topics |
- Allylbenzene Derivatives
- Animals
- Animals, Newborn
- Anisoles
(metabolism, toxicity)
- Carcinogens
- Carcinoma, Hepatocellular
(chemically induced, pathology)
- Flavoring Agents
(metabolism, toxicity)
- Glucuronates
(metabolism)
- Liver
(metabolism)
- Liver Neoplasms
(chemically induced, pathology)
- Male
- Mice
- Mutagens
- Neoplasms, Experimental
(chemically induced, pathology)
- Nucleosides
(metabolism)
- Salmonella typhimurium
(drug effects)
|